Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $195,333 | 57 | 83.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25,485 | 15 | 10.9% |
| Travel and Lodging | $10,336 | 33 | 4.4% |
| Food and Beverage | $2,961 | 30 | 1.3% |
| Education | $47.77 | 4 | 0.0% |
| Entertainment | $28.11 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| 4DMedical USA Inc | $108,486 | 26 | $0 (2024) |
| PFIZER INC. | $63,094 | 46 | $0 (2024) |
| Exelixis Inc. | $22,807 | 17 | $0 (2022) |
| Eisai Inc. | $22,128 | 25 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $6,253 | 8 | $0 (2020) |
| Merck Sharp & Dohme LLC | $5,000 | 4 | $0 (2022) |
| Kyowa Kirin, Inc. | $2,787 | 3 | $0 (2024) |
| VENTANA MEDICAL SYSTEMS, INC. | $1,526 | 2 | $0 (2018) |
| Janssen Research & Development, LLC | $1,500 | 3 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $469.32 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $65,251 | 18 | 4DMedical USA Inc ($62,397) |
| 2023 | $46,159 | 15 | 4DMedical USA Inc ($46,089) |
| 2022 | $3,463 | 7 | Exelixis Inc. ($1,980) |
| 2021 | $16,063 | 6 | Exelixis Inc. ($9,900) |
| 2020 | $17,390 | 16 | AstraZeneca Pharmaceuticals LP ($5,203) |
| 2019 | $6,548 | 8 | EISAI INC. ($4,915) |
| 2018 | $22,058 | 26 | PFIZER INTERNATIONAL LLC ($13,767) |
| 2017 | $57,261 | 44 | PFIZER INC. ($47,787) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/15/2024 | 4DMedical USA Inc | CT LVAS (Device) | Consulting Fee | Cash or cash equivalent | $5,330.21 | General |
| Category: Lung imaging software and device | ||||||
| 11/15/2024 | 4DMedical USA Inc | CT LVAS (Device) | Consulting Fee | Cash or cash equivalent | $5,330.21 | General |
| Category: Lung imaging software and device | ||||||
| 10/15/2024 | 4DMedical USA Inc | CT LVAS (Device) | Consulting Fee | Cash or cash equivalent | $5,330.21 | General |
| Category: Lung imaging software and device | ||||||
| 09/15/2024 | 4DMedical USA Inc | CT LVAS (Device) | Consulting Fee | Cash or cash equivalent | $5,330.21 | General |
| Category: Lung imaging software and device | ||||||
| 08/15/2024 | 4DMedical USA Inc | CT LVAS (Device) | Consulting Fee | Cash or cash equivalent | $5,330.21 | General |
| Category: Lung imaging software and device | ||||||
| 08/01/2024 | Kyowa Kirin, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,962.50 | General |
| 08/01/2024 | Kyowa Kirin, Inc. | — | Travel and Lodging | Cash or cash equivalent | $39.18 | General |
| 07/01/2024 | 4DMedical USA Inc | CT LVAS (Device) | Consulting Fee | Cash or cash equivalent | $5,330.21 | General |
| Category: Lung imaging software and device | ||||||
| 06/01/2024 | 4DMedical USA Inc | CT LVAS (Device) | Consulting Fee | Cash or cash equivalent | $5,330.21 | General |
| Category: Lung imaging software and device | ||||||
| 05/31/2024 | 4DMedical USA Inc | CT LVAS (Device) | Travel and Lodging | In-kind items and services | $766.86 | General |
| Category: Lung imaging software and device | ||||||
| 05/01/2024 | 4DMedical USA Inc | CT LVAS (Device) | Consulting Fee | Cash or cash equivalent | $5,330.21 | General |
| Category: Lung imaging software and device | ||||||
| 04/19/2024 | Iovance Biotherapeutics, Inc. | Amtagvi (Drug) | Food and Beverage | Cash or cash equivalent | $49.25 | General |
| Category: Oncology | ||||||
| 04/11/2024 | Kyowa Kirin, Inc. | — | Consulting Fee | Cash or cash equivalent | $785.00 | General |
| 04/01/2024 | 4DMedical USA Inc | CT LVAS (Device) | Consulting Fee | Cash or cash equivalent | $4,747.02 | General |
| Category: Lung imaging software and device | ||||||
| 03/01/2024 | 4DMedical USA Inc | CT LVAS (Device) | Consulting Fee | Cash or cash equivalent | $4,747.02 | General |
| Category: Lung imaging software and device | ||||||
| 02/27/2024 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $18.00 | General |
| Category: ONCOLOGY | ||||||
| 02/01/2024 | 4DMedical USA Inc | CT LVAS (Device) | Consulting Fee | Cash or cash equivalent | $4,747.02 | General |
| Category: Lung imaging software and device | ||||||
| 01/01/2024 | 4DMedical USA Inc | CT LVAS (Device) | Consulting Fee | Cash or cash equivalent | $4,747.02 | General |
| Category: Lung imaging software and device | ||||||
| 12/01/2023 | 4DMedical USA Inc | — | Consulting Fee | Cash or cash equivalent | $4,747.02 | General |
| 12/01/2023 | 4DMedical USA Inc | — | Consulting Fee | Cash or cash equivalent | $783.85 | General |
| 11/01/2023 | 4DMedical USA Inc | — | Consulting Fee | Cash or cash equivalent | $3,963.17 | General |
| 10/01/2023 | 4DMedical USA Inc | — | Consulting Fee | Cash or cash equivalent | $3,963.17 | General |
| 09/01/2023 | 4DMedical USA Inc | — | Consulting Fee | Cash or cash equivalent | $3,963.17 | General |
| 08/01/2023 | 4DMedical USA Inc | — | Consulting Fee | Cash or cash equivalent | $3,429.66 | General |
| 07/01/2023 | 4DMedical USA Inc | — | Consulting Fee | Cash or cash equivalent | $3,588.71 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 49 | 156 | $53,324 | $12,847 |
| 2022 | 1 | 35 | 149 | $47,812 | $11,983 |
| 2021 | 1 | 37 | 168 | $48,999 | $13,672 |
| 2020 | 2 | 50 | 193 | $53,204 | $13,442 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 38 | 145 | $46,678 | $11,197 | 24.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 11 | 11 | $6,646 | $1,650 | 24.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 35 | 149 | $47,812 | $11,983 | 25.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 37 | 168 | $48,999 | $13,672 | 27.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 37 | 180 | $46,080 | $11,622 | 25.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 13 | 13 | $7,124 | $1,821 | 25.6% |
About Dr. Robert Figlin, MD
Dr. Robert Figlin, MD is a Hematology & Oncology healthcare provider based in Duarte, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780609966.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Figlin, MD has received a total of $234,191 in payments from pharmaceutical and medical device companies, with $65,251 received in 2024. These payments were reported across 140 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($195,333).
As a Medicare-enrolled provider, Figlin has provided services to 171 Medicare beneficiaries, totaling 666 services with total Medicare billing of $51,945. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Duarte, CA
- Active Since 07/12/2006
- Last Updated 05/21/2010
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1780609966
Products in Payments
- CT LVAS (Device) $62,397
- SUTENT (Drug) $52,633
- Lenvima (Drug) $22,128
- Cabometyx (Drug) $12,774
- CABOMETYX (Drug) $9,900
- BENCHMARK IHC/ISH PLATFORMS & REAGENTS (Device) $1,526
- WELIREG (Drug) $500.00
- FOTIVDA (Drug) $70.15
- Amtagvi (Drug) $49.25
- INLYTA (Drug) $38.94
- VOTRIENT (Drug) $22.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Duarte
Dr. Christine Lovly, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $302,848
Lihua Budde, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $223,363
Dr. Leslie Popplewell, M.d, M.D
Hematology & Oncology — Payments: $206,204
Mrs. Tanya Dorff, M.d, M.D
Hematology & Oncology — Payments: $198,135
Dr. Michael Rosenzweig, M.d, M.D
Hematology & Oncology — Payments: $136,718
Dr. Steven Rosen, M.d, M.D
Hematology & Oncology — Payments: $111,332